👇 Don't miss CRI's highlighted sessions today at #SITC25! For our full program of selected presentations @sitcancer, and more resources for immunotherapy researchers, visit our website: https://t.co/2vNiGnAVEb #Immunotherapy #CancerResearch #CancerResearcher

At a #SITC25 panel on future cancer research $$, our CEO Dr. Alicia Zhou shared that in the current environment, we should think differently in terms of finding projects & areas of study - to ensure the work is going to have impact, both scientifically & ideally transitionally

The award-winning documentary that Sen. Adam Schiff demanded to have removed from Amazon Prime shows how metabolic and other natural cancer treatments work. "We're not giving cancer an opportunity to detour . . . to escape down one of its usual [biochemical] pathways."

Explore the momentum and future of cancer research funding with industry leaders including CRI's CEO, Dr. Alicia Zhou, @DanaFarber's Dr. Catherine Wu, and more, in a #SITC25 panel discussion co-chaired by @IcahnMountSinai's Dr. Miriam Merad and @parkerici's Dr. Ira Mellman.

👋 Stop by Booth #305 at #SITC25 today to explore CRI’s full range of grants, fellowships, and awards supporting the next generation of cancer immunotherapy researchers! Visit our website for more resources: https://t.co/2vNiGnAVEb #CancerResearch #Immunotherapy #CancerResearcher

Review CRI's highlights of today's sessions and presentations at #SITC25! Visit our website for our full list of selections, featuring CRI-affiliated scientists: https://t.co/2vNiGnAVEb #CancerResearch #Immunotherapy #CancerResearcher #SITC

Introducing the next generation of YC founders. They’re avatars. 👀 Deadline to apply: Nov 10 @garrytan @saranormous @snowmaker @bosmeny @_ram_ @sdianahu @eladgil @sama @ballmatthew @GJarrosson @levie @eglyman @gokulr @terronk @skeptrune @lina_colucci @IbrahimAjami @hazhubble

Check out our @pitt_immunology expert, Dr. Tullia Bruno (@BcellBruno) who presents her research later today on B cell exhaustion in #Cancer tumors. Session 107 | 3:55 pm |Maryland Ballroom #SITC2025 @PittHealthSci @UPMCnews @UPMCPhysicianEd

📆 Join CRI's CEO, Dr. Alicia Zhou, tomorrow for a panel discussion at #SITC25's Session 205c: The Momentum and Future of Cancer Research Funding. Can't attend? Read our blog to discover how CRI is standing firm in the face of federal funding cuts: https://t.co/HObHIQUQd5

CRI is at #SITC25! Connect with us at Booth #305 to learn about our fellowships, grants, and awards that help support scientists advancing cancer immunotherapy. #CancerResearch #FundingOpportunity @sitcancer

Attending #SITC25 today? Check out CRI's highlighted selection of sessions and presentations, and visit our website for more resources: https://t.co/2vNiGnAVEb @sitcancer #Immunotherapy #CancerResearch #CancerResearcher

At the #SITC25 Keynote Address, Jennifer Wargo, MD (@JenWargoMD) explores how targeting the microbiome can promote health and help end cancer — from gut microbes and diet to the tumor microenvironment and brain tumors. #MoffittSITC25

Excited to be at the 40th Anniversary #SITC25 Annual Meeting! Looking forward to the latest breakthroughs and new opportunities to accelerate progress in immunotherapy for patients. Thank you, @sitcancer, for bringing us together! @MoffittNews #Immunotherapy #MoffittSITC25

🚀 @Thorwallet integrates @NEARProtocol Intents, unlocking a new layer of intent-based swap routes across dozens of blockchains. You can now swap seamlessly across multiple chains including Sui, Solana, Bitcoin, Ethereum, BNB, Stellar, and more. Plus some new comers: $TRON &

Recent federal actions have posed challenges to the biomedical research landscape so it's essential to unite our community to exchange knowledge. Join a SITC Member-Only Town Hall Webinar, "The State of Play in Immunotherapy Research" on Nov. 10. Register: https://t.co/VD1guMWIT8

The Sparkathon program brought early career investigators to connect with established leaders in cancer immunotherapy at #SITC25! Special thanks to organizers @MarcoRuella and @JennGuerriero.

Wonderful summary resource from @CancerResearch @ay_zhou et al: The global landscape of cancer cell therapies, clinical trial trends and emerging directions https://t.co/v5YDLlBDbB @NatRevDrugDisc

Cancer cell therapies: global clinical trial trends and emerging directions https://t.co/g1E5PLbssu This new article by authors @CancerResearch analyses trends across trial phases, indications, modalities, cell sources and targets to map the current trajectory of the field

In CRI Scientific Advisory Council member Dr. Miriam Merad's mind @IcahnMountSinai, @statnews describes, "the horizons for macrophages extend far beyond cancer." Explore: https://t.co/wnqQpwrZzw #CancerResearch #CancerResearcher #Immunotherapy #Macrophages

#CCTG & @CancerResearch announce the first patient enrolled in a new sub-study of the #IPROC ovarian cancer immunotherapy platform trial - new immunotherapy combination & patient population, accelerating progress toward effective ovarian cancer treatments. https://t.co/yHIDkgPYBl

🔬 The CRI Technology Impact Award is designed to support the earliest stages of innovation- concepts that haven't yet been built or tested, but have potential to transform cancer #immunotherapy. Submit your Letter of Intent by Nov. 15: https://t.co/ahgTJujoak #FundingOpportunity

For 70+ years, CRI has been at the center of immunotherapy's story, funding breakthrough discoveries, backing bold scientists, and keeping alive the idea that immune-based treatments could change cancer care. Dive into this transformative timeline today:

“Our new platform offers broad hopes for developing distinct programs to treat not only cancer, but a wide range of different diseases,” says CRI Lloyd J. Old STAR Dr. Alex Marson, co-senior author of the study @GladstoneInst @UCSF: https://t.co/ZYhpuHpuCx #CART #CancerResearch